Murine monoclonal antibodies (MAbs) gp41-1 (IgG2a) and gp41-2 (IgG1), directed against the envelope glycoprotein of human immunodeficiency virus type 1 (HIV-1), were produced and characterized. These MAbs recognized both gp160 and gp41 and reacted with divergent HIV-1 isolates. Surface binding assays using viable HIV-infected cells indicated that these MAbs were directed against surface-exposed epitopes. Both MAbs caused a reduction in reverse transcriptase activity. Syngeneic monoclonal anti-idiotypic antibodies (anti-ids) against gp41-1 were also generated. Six anti-ids (agp41-11 to agp41-16) were selected by ELISA using F(ab′)2 fragments of gp41-1; no reaction was observed when fragments from an irrelevant IgG2a MAb were used. Anti-ids were recognized by both gp41-1 and gp41-2 biotinylated MAbs. Competitive ELISA studies suggested that anti-ids were directed against at least three distinct idiotopes on gp41-1. All anti-ids reacted with idiotopes associated with both heavy and light chains and not with separated chains. The binding of MAbs gp41-1 and gp41-2 to HIV-infected cells was inhibited by each anti-id, except for the binding of gp41-2 which was not affected by the presence of agp41-12. Immunization of rabbits with agp41-11 and agp41-13 resulted in an antibody response against recombinant gp160. These studies indicated that these two anti-ids contain a surrogate image of the antigen recognized by gp41-1.
AmitA. G.,
MariuzzaR. A.,
PhillipsS. E. V.,
PoljakR. J.1986; Three dimensional structure of an antigen-antibody complex at 2.8 Å resolution. Science 233:747–753
ArthurL. O.,
PyleS. W.,
NaRaP. L.,
BessJ. W.Jr,
GondaM. A.,
KelliherJ. C.,
GildeNR. V.,
RobeyW. G.,
BolognesiD. P.,
GalloR. C.,
FischingerP. J.1987; Serological responses in chimpanzees inoculated with human immunodeficiency virus glycoprotein (gp120) subunit vaccine. Proceedings of the National Academy of Sciences, U.S.A. 84:8583–8587
BerettaA.,
GrassiF.,
PelagiM.,
ClivioA.,
ParraviciniC.,
GiovinazzoG.,
AndronicoF.,
LopalcoF.,
VeraniP.,
ButtoS.,
TittiF.,
RossiG. B.,
VialeG.,
GinelliE.,
SiccardiA. G.1987; HIV env glycoprotein shares a cross-reactive epitope with a surface protein present on activated human monocytes and involved in antigen presentation. European Journal of Immunology 17:1793–1798
BermanP. W.,
GroopmanJ. E.,
GregoryT.,
ClaphamP. R.,
WeissR. A.,
FerrianiR.,
RiddleL.,
ShimasakiC.,
LucasC.,
LaskyL. A.,
EichbergJ. W.1988; Human immunodeficiency virus type 1 challenge of chimpanzees immunized with recombinant envelope glycoprotein gpl20. Proceedings of the National Academy of Sciences, U.S.A. 85:5200–5204
BrodeurB. R.,
LaroseY.,
TsangP.,
HamelJ.,
AshtonF.,
RyanA.1985; Protection against infection with Neisseria meningitidis group B serotype 2b by passive immunization with serotype-specific monoclonal antibody. Infection and Immunity 50:510–516
CazenaveP. A.1977; Idiotypic-anti-idiotypic regulation of antibody synthesis in rabbits. Proceedings of the National Academy of Sciences, U.S.A 74:5122–5125
ChirmuleN.,
KalyanaramanV.,
OyaizuN.,
PahwaS.1988; Inhibitory influences of envelope glycoproteins of HIV-1 on normal immune responses. Journal of Acquired Immune Deficiency Syndrome 1:425–430
DalgleishA. G.,
ChanhT. C.,
KennedyR. C.,
KandaP.,
ClaphamP. R.,
WeissR. A.1988; Neutralization of diverse HIV-1 strains by monoclonal antibodies raised against a gp41 synthetic peptide. Virology 165:209–215
DiamondD. C.,
SleckmanB. P.,
GregoryT.,
LaskyL. A.,
GreensteinJ. L.,
BurakoffS. J.1988; Inhibition of CD4+ T cell function by the envelope protein, gpl20. Journal of Immunology 141:3715–3717
Di Marzo VeroneseF.,
de VicoA. L.,
CopelandT. D.,
OroszlanS.,
GalloR. C.,
SarngadharanM. G.1985; Characterization of gp41 as the transmembrane protein encoded by the HTLV-III/LAV envelope gene. Science 229:1402–1405
DupuisG.,
BastinB.1985; Binding of phytohemagglutinin to porcine lymphocyte receptors. Time-course studies and comparative binding isotherms using whole cells or cellular receptors incorporated into phospholipid vesicles. Canadian Journal of Biochemistry and Cell Biology 63:1033–1043
EvansL. A.,
Thomson-HonnebierG.,
SteimerK.,
PaolettiE.,
PERKUSM. E.,
HOLLANDERH.,
LEVYJ. A.1989; Antibody-dependent cellular cytotoxicity is directed against both the gp120 and gp41 envelope proteins of HIV. AIDS 3:273–276
FaucherS.,
CardinJ.,
TalbotB.,
DupuisG.1989; Properties of three monoclonal antibodies that recognize an 80-KDa phytohemagglutinin-binding glycoprotein from porcine lymphocytes. Canadian Journal of Biochemistry and Cell Biology 67:224–232
GnannJ. W.Jr,
SchwimmbeckP. L.,
NelsonJ. A.,
TruaxA. B.,
OldstoneM. B. A.1987a; Diagnosis of AIDS by using a 12-amino acid peptide representing an immunodominant epitope of the human immunodeficiency virus. Journal of Infectious Diseases 156:261–267
GnannJ. W.Jr,
NelsonJ. A.,
OldstoneM. B. A.1987b; Fine mapping of an immunodominant domain in the transmembrane glycoprotein of human immunodeficiency virus. Journal of Virology 61:2639–2641
GoldingH.,
ShearerG. M.,
HillmanK.,
LucasP.,
Man-IschewitzJ.,
ZajacR. A.,
ClericiM.,
GressR. E.,
BoswellR. N.,
GoldingB.1989; Common epitope in human immunodeficiency virus (HIV) I-gp41 and HLA class II elicits immunosuppressive autoantibodies capable of contributing to immune dysfunction in HIV I-infected individuals. Journal of Clinical Investigation 83:1430–1435
HamelJ.,
BrodeurB. R.1990; Induction of an immune response to the porin of Haemophilus influenzae type b by monoclonal antiidiotypic antibodies. Microbial Pathogenesis8 (in press)
HamelJ.,
BrodeurB. R.,
LaroseY.,
TsangP. S.,
BelmaazaA.,
MontplaisirS.1987; A monoclonal antibody directed against a serotype-specific, outer-membrane protein of Haemophilus influenzae type B. Journal of Medical Microbiology 23:163–170
HaseltineW. A.,
TerwilligerE. F.,
RosenC. A.,
SodroskiJ. G.1990; Structure and function of human pathogenic retroviruses. In Retrovirus Biology and Human Disease pp. 241–283 Edited by
GalloR. C.,
Wong-StaalF.
New York: Marcel Dekker;
HiernauxJ.,
BonaC. A.,
BakerP. J.1981; Neonatal treatment with low doses of anti-idiotypic antibody leads to the expression of a silent clone. Journal of Experimental Medicine 153:1004–1008
HuS. L.,
FultzP. N.,
McClureH. M.,
EichbergJ. W.,
ThomasE. K.,
ZarlingJ.,
SinghalM. C.,
KosowskiS. G.,
SwensonR. B.,
AndersonD. C.,
TodaroG.1987; Effect of immunization with a vaccinia-HIV env recombinant on HIV infection of chimpanzees. Nature, London 328:721–723
KennedyR. C.,
HenkelR. D.,
DreesmanG. R.1986a; Further characterization of internal image-bearing anti-idiotypic antibodies: specific binding to immunoglobulin receptors on murine hybridoma cells secreting antibodies to hepatitis B surface antigen. Scandinavian Journal of Immunology 23:481–489
KowalskiM.,
PotzJ.,
BasiripourL.,
DorfmanT.,
GohW. C.,
TerwilligerE.,
DaytonA.,
RosenC.,
HaseltineW.,
SodroskiJ.1987; Functional regions of the envelope glycoprotein of human immunodeficiency virus type 1. Science 237:1351–1355
KrustB.,
LaurentA. G.,
MontagnierL.,
HovanessianA. G.1987; A sensitive dot immunobinding assay for the detection of antibodies specific for HIV. Annales de l’Institut Pasteur/Virology 138:245–252
LifsonJ. D.,
FeinbergM. B.,
ReyesG. R.,
RabinL.,
BanapourB.,
ChakrabartiS.,
MossB.,
Wong-StaalF.,
SteimerK. S.,
EnglemanE. G.1986; Induction of CD4-dependent cell fusion by the HTLV-III/LAV envelope glycoprotein. Nature, London 323:725–728
LussierM.,
BrodeurB. R.,
WinstonS.1989; Detection of Neisseria gonorrhoeae by dot-enzyme immunoassay using monoclonal antibodies. Journal of Immunoassay 10:373–394
McDougalJ. S.,
KennedyM. S.,
SlighJ. M.,
CortS. P.,
MawleA.,
NicholsonJ. K. A.1986; Binding of HTLV-III/LAV to T4+ T cells by a complex of the 110K viral protein and the T4 molecule. Science 231:382–385
MyersG.,
RabsonA. B.,
JosephsS. F.,
SmithT. F.,
BerzofskyJ. A.,
Wong-StaalF.
(editors) 1989; Compilation and analysis of nucleic acid and amino acid sequences. In Human Retroviruses and AIDS 1989 pp III-61–III-67 New Mexico: Los Alamos National Laboratory;
NeumannP. W.,
BenningB. J.,
RobinsonD. G.,
GilmoreN.,
O’ShaughnessyM. V.1986; HTLV-III infection in Canada in 1985. Canadian Medical Association Journal 135:477–480
NisonoffA.,
LaMOYiE.1981; Implication of the presence of an internal image of the antigen in anti-idiotypic antibodies: possible application to vaccine production. Clinical Immunology 21:397–406
OsterhausA. D. M. E.,
BunschotenE. J.,
WeijerK.,
UytdeHaagF. G. C. M.1988; Modulation of the immune system towards antiviral immune response using anti-idiotypic structures. In Biological Applications of Anti-Idiotypes vol. II pp. 13–30 Edited by
BonaC. A.
Boca Raton: CRC Press;
ResnickL.,
Di Marzo VeroneseF.,
SchuppbachJ.,
Tourtel-LotteW. W.,
HoD. D.,
MullerF.,
ShapshakP.,
VogtM.,
GroopmanJ. E.,
MarkhamP. D.,
GalloR. C.1985; Intrablood-brain-barrier synthesis of HTLV-III-specific IgG in patients with neurologic symptoms associated with AIDS or AIDS-related complex. New England Journal of Medicine 313:1498–1504
RobeyW. G.,
SafaiB.,
OroszlanS.,
ArthurL. O.,
GondaM. A.,
GalloR. C.,
FischingerP. J.1985; Characterization of envelope and core structural gene products of HTLV-III with sera from AIDS patients. Science 222:593–595
SandstromE. G.,
SchooleyR. T.,
HoD. D.,
ByingtonR.,
SarngadharanM. G.,
MacLaneM. E.,
EssexM.,
GalloR. C.,
HirschM. S.1985; Detection of human anti-HTLV-III antibodies by indirect immunofluorescence using fixed cells. Transfusion 25:308–312
SodroskiJ.,
GohW. C.,
RosenC.,
CampbellK.,
HaseltineW. A.1986; Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity. Nature, London 322:470–474
StarcichB. R.,
HahnB. H.,
ShawG. M.,
McNeelyP. D.,
ModrowS.,
WolfH.,
ParksE. S.,
ParksW. P.,
JosephsS. F.,
GalloR. C.,
Wong-StaalF.1986; Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, the retrovirus of AIDS. Cell 45:637–648
SteinB. S.,
GowdaS. D.,
LifsonJ. D.,
PenhallowR. C.,
BenschK. G.,
EnglemanE. G.1987; pH-independent HIV entry into CD4-positive T cells via virus envelope fusion to the plasma membrane. Cell 49:659–668
TowbinH.,
StaehelinT.,
GordonJ.1979; Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proceedings of the National Academy of Sciences, U.S.A. 76:4350–4354
UrbainJ.,
WiklerM.,
FranssenJ. D.,
CollignonC.1977; Idiotypic regulation of the immune system by the induction of antibodies against anti-idiotypic antibodies. Proceedings of the National Academy of Sciences, U.S.A 74:5126–5130
WeigentD. A.,
HoeprichP. D.,
BostK. L.,
BrunckT. K.,
ReiherW. E.III,
BlalockJ. E.1986; The HTLV-III envelope protein contains a hexapeptide homologous to a region of interleukin-2 receptor. Biochemical and Biophysical Research Communications 139:367–374
WeinholdK. J.,
LyerlyH. K.,
StanleyS. D.,
AustinA. A.,
MatthewsT. J.,
BolognesiD. P.1989; HIV-1 gp120-mediated immune suppression and lymphocyte destruction in the absence of viral infection. Journal of Immunology 142:3091–3097
ZarlingJ. M.,
EichbergJ. W.,
MoranP. A.,
McClureJ.,
SridharP.,
HuS. L.1987; Proliferative and cytotoxic T cells to AIDS virus glycoproteins in chimpanzees immunized with a recombinant vaccinia virus expressing AIDS virus envelope glycoproteins. Journal of Immunology 139:988–990
ZhouE.-M.,
ChanhT. C.,
DreesmanG. R.,
KandaP.,
KennedyR. C.1987; Immune response to human immunodeficiency virus. In vivo administration of anti-idiotype induces an anti-gp160 response specific for a synthetic peptide. Journal of Immunology 139:2950–2956